Insufficient scRNA-seq data for expression of TMIGD3 at single-cell level.
Insufficient scRNA-seq data for expression of TMIGD3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 84% | 330.89 | 2225 / 2642 | 99% | 27.48 | 695 / 705 |
adrenal gland | 99% | 572.41 | 256 / 258 | 58% | 2.65 | 133 / 230 |
lung | 75% | 230.21 | 434 / 578 | 77% | 2.96 | 886 / 1155 |
breast | 70% | 118.41 | 320 / 459 | 81% | 2.57 | 906 / 1118 |
bladder | 76% | 72.05 | 16 / 21 | 52% | 1.90 | 262 / 504 |
intestine | 79% | 141.37 | 763 / 966 | 32% | 0.85 | 171 / 527 |
kidney | 30% | 47.49 | 27 / 89 | 79% | 3.36 | 712 / 901 |
ovary | 25% | 25.36 | 45 / 180 | 77% | 2.41 | 329 / 430 |
skin | 19% | 19.19 | 341 / 1809 | 82% | 3.59 | 388 / 472 |
pancreas | 15% | 16.17 | 50 / 328 | 85% | 3.26 | 151 / 178 |
spleen | 92% | 525.32 | 222 / 241 | 0% | 0 | 0 / 0 |
uterus | 26% | 25.63 | 45 / 170 | 60% | 1.97 | 277 / 459 |
liver | 54% | 97.75 | 122 / 226 | 33% | 1.05 | 132 / 406 |
adipose | 85% | 225.74 | 1026 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 40% | 46.51 | 576 / 1445 | 44% | 1.07 | 80 / 183 |
stomach | 38% | 40.28 | 138 / 359 | 42% | 0.94 | 119 / 286 |
lymph node | 0% | 0 | 0 / 0 | 79% | 4.50 | 23 / 29 |
thymus | 37% | 38.74 | 241 / 653 | 41% | 0.95 | 248 / 605 |
blood vessel | 66% | 118.82 | 879 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 61% | 465.77 | 568 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 1.64 | 27 / 45 |
prostate | 47% | 54.81 | 115 / 245 | 10% | 0.14 | 50 / 502 |
heart | 38% | 55.42 | 330 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 25% | 0.68 | 20 / 80 |
muscle | 6% | 6.27 | 52 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0007190 | Biological process | activation of adenylate cyclase activity |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006954 | Biological process | inflammatory response |
GO_0009611 | Biological process | response to wounding |
GO_0008016 | Biological process | regulation of heart contraction |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
Gene name | TMIGD3 |
Protein name | Transmembrane and immunoglobulin domain containing 3 Transmembrane domain-containing protein TMIGD3 |
Synonyms | UNQ1931/PRO4406 |
Description | FUNCTION: [Isoform 1]: Plays a suppressive role in osteosarcoma malignancy by inhibiting NF-kappa-B activity . . |
Accessions | ENST00000369716.9 [P0DMS9-2] ENST00000472933.2 A0A0J9YY46 P0DMS9 ENST00000369717.8 [P0DMS9-1] ENST00000443498.5 Q5QNY8 |